Literature DB >> 23820886

MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met.

Xin Xu1, Hong Chen, Yiwei Lin, Zhenghui Hu, Yeqing Mao, Jian Wu, Xianglai Xu, Yi Zhu, Shiqi Li, Xiangyi Zheng, Liping Xie.   

Abstract

There is increasing evidence suggesting that dysregulation of certain microRNAs (miRNAs) may contribute to tumor progression and metastasis. Previous studies have shown that miR-409-3p is dysregulated in some malignancies, but its role in bladder cancer is still unknown. Here, we find that miR-409-3p is down-regulated in human bladder cancer tissues and cell lines. Enforced expression of miR-409-3p in bladder cancer cells significantly reduced their migration and invasion without affecting cell viability. Bioinformatics analysis identified the pro-metastatic gene c-Met as a potential miR-409-3p target. Further studies indicated that miR-409-3p suppressed the expression of c-Met by binding to its 3'-untranslated region. Silencing of c-Met by small interfering RNAs phenocopied the effects of miR-409-3p overexpression, whereas restoration of c-Met in bladder cancer cells bladder cancer cells overexpressing miR-409-3p, partially reversed the suppressive effects of miR-409-3p. We further showed that MMP2 and MMP9 may be downstream effector proteins of miR-409-3p. These findings indicate that miR-409-3p could be a potential tumor suppressor in bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23820886      PMCID: PMC3887926          DOI: 10.1007/s10059-013-0044-7

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  27 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  Met, metastasis, motility and more.

Authors:  Carmen Birchmeier; Walter Birchmeier; Ermanno Gherardi; George F Vande Woude
Journal:  Nat Rev Mol Cell Biol       Date:  2003-12       Impact factor: 94.444

Review 3.  Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs.

Authors:  David P Bartel; Chang-Zheng Chen
Journal:  Nat Rev Genet       Date:  2004-05       Impact factor: 53.242

4.  Most mammalian mRNAs are conserved targets of microRNAs.

Authors:  Robin C Friedman; Kyle Kai-How Farh; Christopher B Burge; David P Bartel
Journal:  Genome Res       Date:  2008-10-27       Impact factor: 9.043

5.  MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.

Authors:  Alessandro Salvi; Cristiano Sabelli; Silvia Moncini; Marco Venturin; Bruna Arici; Paola Riva; Nazario Portolani; Stefano M Giulini; Giuseppina De Petro; Sergio Barlati
Journal:  FEBS J       Date:  2009-04-16       Impact factor: 5.542

6.  MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer.

Authors:  Yunfeng Zhou; Deyao Wu; Jun Tao; Ping Qu; Zhengdong Zhou; Jianquan Hou
Journal:  Scand J Urol       Date:  2012-12-04       Impact factor: 1.612

Review 7.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

8.  miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.

Authors:  Na Li; Hanjiang Fu; Yi Tie; Zheng Hu; Wei Kong; Yongge Wu; Xiaofei Zheng
Journal:  Cancer Lett       Date:  2008-11-08       Impact factor: 8.679

9.  Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.

Authors:  R B Hazan; G R Phillips; R F Qiao; L Norton; S A Aaronson
Journal:  J Cell Biol       Date:  2000-02-21       Impact factor: 10.539

10.  Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder.

Authors:  H-L Cheng; H-S Liu; Y-J Lin; H H-W Chen; P-Y Hsu; T-Y Chang; C-L Ho; T-S Tzai; N-H Chow
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

View more
  48 in total

1.  MicroRNA-409-3p suppresses cell proliferation and cell cycle progression by targeting cyclin D2 in papillary thyroid carcinoma.

Authors:  Zhijun Zhao; Fei Yang; Yan Liu; Kai Fu; Shanghua Jing
Journal:  Oncol Lett       Date:  2018-08-01       Impact factor: 2.967

2.  miR-409-3p suppresses the proliferation, invasion and migration of tongue squamous cell carcinoma via targeting RDX.

Authors:  Hujie Chen; Jing Dai
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

3.  Promoter demethylation of nuclear factor-erythroid 2-related factor 2 gene in drug-resistant colon cancer cells.

Authors:  Xiao-Qian Zhao; Yi-Fei Zhang; Yi-Fang Xia; Zhong-Mei Zhou; Ying-Qing Cao
Journal:  Oncol Lett       Date:  2015-07-08       Impact factor: 2.967

4.  miR-148a dependent apoptosis of bladder cancer cells is mediated in part by the epigenetic modifier DNMT1.

Authors:  Alan P Lombard; Benjamin A Mooso; Stephen J Libertini; Rebecca M Lim; Rachel M Nakagawa; Kathleen D Vidallo; Nicole C Costanzo; Paramita M Ghosh; Maria Mudryj
Journal:  Mol Carcinog       Date:  2015-04-11       Impact factor: 4.784

5.  Inhibition of miR-1247 on cell proliferation and invasion in bladder cancer through its downstream target of RAB36.

Authors:  Yudi Zhu; Shaosi Liang; Huafeng Pan; Zhongliang Cheng; Xin Rui
Journal:  J Biosci       Date:  2018-06       Impact factor: 1.826

6.  MIR-300 in the imprinted DLK1-DIO3 domain suppresses the migration of bladder cancer by regulating the SP1/MMP9 pathway.

Authors:  Huaqing Yan; Jiangfeng Li; Yufan Ying; Haiyun Xie; Hong Chen; Xin Xu; Xiangyi Zheng
Journal:  Cell Cycle       Date:  2018-12-18       Impact factor: 4.534

7.  miR-613 inhibits bladder cancer proliferation and migration through targeting SphK1.

Authors:  Haifeng Yu; Ping Duan; Haibo Zhu; Dapang Rao
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

Review 8.  Dysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistance.

Authors:  Joseph J Sacco; Michael J Clague
Journal:  Transl Lung Cancer Res       Date:  2015-06

9.  A long non-coding RNA snaR contributes to 5-fluorouracil resistance in human colon cancer cells.

Authors:  Heejin Lee; Chongtae Kim; Ja-Lok Ku; Wook Kim; Sungjoo Kim Yoon; Hyo-Jeong Kuh; Jeong-Hwa Lee; Suk Woo Nam; Eun Kyung Lee
Journal:  Mol Cells       Date:  2014-07-31       Impact factor: 5.034

10.  Novel nanopolymer RNA therapeutics normalize human diabetic corneal wound healing and epithelial stem cells.

Authors:  Andrei A Kramerov; Ruchi Shah; Hui Ding; Eggehard Holler; Sue Turjman; Yaron S Rabinowitz; Sean Ghiam; Ezra Maguen; Clive N Svendsen; Mehrnoosh Saghizadeh; Julia Y Ljubimova; Alexander V Ljubimov
Journal:  Nanomedicine       Date:  2020-11-10       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.